Heesoo Joo

Heesoo Joo

Auto-generated profile, based on publicly available information

Heesoo Joo

COVID-19 Response (Drs Dunphy, Joo, Howard-Williams, McCord, Sunshine, Kao, Guy, Weber, and Ekwueme) and Division of Healthcare Quality Promotion (Dr Sapiano), Centers for Disease Control and Prevention, Atlanta, Georgia; Lantana Consulting Group, Thetford, Vermont (Dr Sapiano); and School of Public Health, University of Nevada, Las Vegas, Nevada (Dr Gakh)

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
JLJunsoo Lee
Junsoo Lee
HJHeesoo Joo
Heesoo Joo
BMBrian A. Maskery
Brian A. Maskery
JAJonathan D. Alpern
Jonathan D. Alpern
CPChanhyun Park
Chanhyun Park
WSWilliam Stauffer
William Stauffer
The mean wholesale prices of the antiparasitic drugs albendazole (400 mg; Albenza) and mebendazole (600 mg; Emverm) increased between 2010 and 2019 from $3.16 to $582 for albendazole and from $32 to $2853 for mebendazole.1,2 In this cross-sectional study, the association of antiparasitic drug prices with prescribing and prescription-filling behaviors and total outpatient treatment costs (TOCs) are investigated for hookworm and pinworm. These results are compared with those for Clostridioides difficile, which was selected because of similar outpatient characteristics and available number and specificity of drugs available.

23 September 2022 in Journal of Public Health Management & Practice
Verified
Journal Article
Closed access
CDChristopher Dunphy
Christopher Dunphy
HJHeesoo Joo
Heesoo Joo
MSMathew R. P. Sapiano
Mathew R. P. Sapiano
MHMara Jd Howard-Williams
Mara Jd Howard-Williams
RMRussell JD McCord
Russell JD McCord
DEDonatus U. Ekwueme
Donatus U. Ekwueme
Context: Mask mandates are one form of nonpharmaceutical intervention that has been utilized to combat the spread of SARS-CoV2, the virus that causes COVID-19. Objective: This study examines the association between state-issued mask mandates and changes in county-level and hospital referral region (HRR)–level COVID-19 hospitalizations across the United States. Design: Difference-in-difference and event study models were estimated to examine the association between state-issued mask mandates and COVID-19 hospitalization outcomes. Participants: All analyses were conducted with US county-level data. Interventions: State-issued mask mandates. County-level data on the mandates were collected from executive orders identified on state government Web sites from April 1, 2020, to December 31, 2020. Main Outcome Measures: Daily county-level (and HRR-level) estimates of inpatient beds occupied by patients with confirmed or suspected COVID-19 were collected by the US Department of Health and Human Services. Results: The state issuing of mask mandates was associated with an average of 3.6 fewer daily COVID-19 hospitalizations per 100 000 people (P < .05) and a 1.2-percentage-point decrease in the percentage of county beds occupied with COVID-19 patients (P < .05) within 70 days of taking effect. Event study results suggest that this association increased the longer mask mandates were in effect. In addition, the results were robust to analyses conducted at the HRR level. Conclusions: This study demonstrated that state-issued mask mandates were associated with reduction in COVID-19 hospitalizations across the United States during the earlier portion of the pandemic. As new variants of the virus cause spikes in COVID-19 cases, reimposing mask mandates in indoor and congested public areas, as part of a layered approach to community mitigation, may reduce the spread of COVID-19 and lessen the burden on our health care system.

1 July 2022 in Journal of Public Health Management & Practice
Verified
Journal Article
Closed access
HJHeesoo Joo
Heesoo Joo
MHMara Jd Howard-Williams
Mara Jd Howard-Williams
RMRussell F. JD McCord
Russell F. JD McCord
GSGregory Jd Sunshine
Gregory Jd Sunshine
JFJames A. Fuller
James A. Fuller
BMBrian A. Maskery
Brian A. Maskery
Trends in the percentages of the US population covered by state-issued nonpharmaceutical interventions (NPIs), including restaurant and bar restrictions, stay-at-home orders, gathering limits, and mask mandates, were examined by using county-specific data sets on state-issued orders for NPIs from March 1, 2020, to August 15, 2021. Most of the population was covered by multiple NPIs early in the pandemic. Most state-issued orders were lifted or relaxed as COVID-19 cases decreased during summer 2020. Few states reimplemented strict NPIs during later surges in US COVID-19 cases over the winter of 2020-2021. The exceptions were mask mandates, which covered about 80% of the population between August 2020 and February 2021, and the most restrictive gathering limits, which covered a maximum of 66% of the population in early 2020 and 68% of the population in winter 2020-2021. Most NPIs were lifted by the end of the analysis period.